CITED2 is a novel direct effector of peroxisome proliferator‐activated receptor γ in suppressing hepatocellular carcinoma cell growth
Open Access
Abstract
BACKGROUND: Previous reports from these authors found that activation of peroxisome proliferator‐activated receptor gamma (PPARγ) suppressed hepatocellular carcinoma (HCC). This study sought to identify the molecular target of PPARγ and characterize its antitumor effect in HCC.METHODS: Optimal PPARγ binding activity was obtained using the PPARγ agonist rosiglitazone (100 μM) as determined by enzyme‐linked immunosorbent assay. Under PPARγ activation, 114 PPARγ downstream targets associated with cancer development were identified by oligonucleotide microarray and Gene Ontology analysis. Among them, Cbp/p300‐interacting transactivator, with Glu/Asp‐rich carboxy‐terminal domain, 2 (CITED2) was the most prominent PPARγ‐bound target, as determined by chromatin immunoprecipitation–polymerase chain reaction.RESULTS: CITED2 messenger RNA and protein was significantly down‐regulated in primary HCCs compared with their adjacent nontumor tissues. PPARγ induced expression of CITED2 in HCC cell lines after adenovirus‐PPARγ transduction. The biological function of CITED2 was evaluated by loss‐ and gain‐of‐function assays. CITED2 knockdown in the hepatocyte cell line LO2 and HCC cell line Hep3B significantly increased cell viability and clonogenicity, and promoted G1‐S phase transition in both cell lines. In contrast, ectopic expression of CITED2 in HepG2 and BEL7404 HCC cell lines significantly suppressed cell growth. The tumor suppressive effect of CITED2 was associated with up‐regulation of cyclin‐dependent kinase inhibitors p15INK4B, p21Wat1/Cip1, p27Kip1, antiproliferative regulator interferon alpha 1, proapoptotic mediators including tumor necrosis factor receptor superfamily member 1A (TNFRSF1A), TNFRSF25, caspase‐8, granzyme A, and the tumor suppressor gene maspin. CITED2 was also associated with the down‐regulation of cell cycle regulator cyclin D1, oncogene telomerase reverse transcriptase, and proinvasion/metastasis gene matrix metallopeptidase 2.CONCLUSIONS: CITED2 is a direct effector of PPARγ for tumor suppression. Cancer 2013. © 2012 American Cancer Society.Keywords
This publication has 28 references indexed in Scilit:
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Maspin (SERPINB5) Is an Obligate Intracellular SerpinJournal of Biological Chemistry, 2010
- Peroxisome Proliferator-Activated Receptor γ Overexpression Suppresses Growth and Induces Apoptosis in Human Multiple Myeloma CellsClinical Cancer Research, 2008
- A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasionFEBS Letters, 2007
- Cited2, a coactivator of HNF4α, is essential for liver developmentThe EMBO Journal, 2007
- A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular CarcinomaJNCI: Journal of the National Cancer Institute, 2005
- Prognostic value of matrix metalloproteinases (MMP-2 and MMP-9) in patients with lymph node-negative breast carcinomaBreast Cancer Research and Treatment, 2004
- Identification of novel direct transcriptional targets of glucocorticoid receptorLeukemia, 2004
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Cancer Cell CyclesScience, 1996